Navigation Links
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
Date:3/10/2011

d at an upcoming medical meeting.

"Bringing new and innovative cancer therapies to patients can be incredibly challenging, especially in difficult-to-treat cancers such as second-line non-small cell lung cancer," said Debasish Roychowdhury, SVP and Head of Global Oncology Division, sanofi-aventis.  "Our Phase III trials of aflibercept in metastatic colorectal cancer and hormone-refractory metastatic prostate cancer are underway to determine the clinical potential of aflibercept for patients with these advanced cancers."

About the VITAL Phase III StudyThe VITAL study was a multinational, randomized, double-blind trial comparing aflibercept versus placebo in combination with docetaxel patients with locally advanced or metastatic non-squamous NSCLC who have failed one platinum-based therapy.  The study enrolled 913 patients who were randomized to receive intravenous (IV) docetaxel 75 mg/m2 plus either IV placebo or IV aflibercept 6 mg/kg every three weeks until disease progression, unacceptable toxicity, patient's refusal or further treatment.  The primary objective of the study was to demonstrate improvement in overall survival with the combination of aflibercept and docetaxel compared with placebo and docetaxel.

About the Aflibercept Clinical Development ProgramSanofi-aventis Oncology and Regeneron are collaborating on a broad oncology development program, combining the investigational agent aflibercept with common chemotherapy regimens in the treatment of patients with advanced cancers.  In addition to VITAL, the program includes two Phase III trials and one Phase II trial, all of which are fully enrolled:

  • VELOUR: Second-line treatment for metastatic colorectal cancer in combination with 5-fluorouracil, leucovorin and irinotecan (FOLFIRI) (Phase III).  Final results are anticipated during the first half of 2011.

  • VENICE: First-line treatment for hormone-refractory metastatic prostate cancer in
    '/>"/>

  • SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
    2. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
    3. Sanofi-aventis Stands Behind the Safety of Lantus(R)
    4. Fovea Pharmaceuticals to be Acquired by sanofi-aventis
    5. Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
    6. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
    7. Sanofi-aventis Obtains Antitrust Clearance in Connection With Chattem, Inc. Tender Offer
    8. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
    9. Sanofi-aventis Commences Tender Offer for All Outstanding Shares of Chattem, Inc.
    10. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
    11. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... "Inferior Vena Cava (IVC) Filters - Global Trends, ... http://photos.prnewswire.com/prnh/20130307/600769 ... to reach US$435 million by 2016. The ... of the global value while Europe ...
    (Date:12/15/2014)... Israel , Dec. 15, 2014  Immune Pharmaceuticals Inc. ... that its Board of Directors has elected Mr. Daniel Kazado ... who continues as Chief Executive Officer of Immune. Mr. Kazado ... 2013. Immune,s new Chairman, Mr. Daniel Kazado ... shareholders and to continue to support the strategic vision of ...
    (Date:12/15/2014)... , Dec. 15, 2014  Colorado and ... have legalized adult use of cannabis. Oregon ... D.C. ended prohibition during the November 2014 elections. ... Photo - http://photos.prnewswire.com/prnh/20141212/164153LOGO The benefits ... noted and obvious benefits like the increased tax revenue for ...
    Breaking Medicine Technology:Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2
    (Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
    (Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
    (Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
    (Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
    (Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
    Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
    ... to a new report by the UNH scientist, the beginning ... The effect, which is a result of global warming, has ... a ripple effect in all the happenings takes place in ... March 20th marking the vernal equinox and the official start ...
    ... a simple and natural remedy for reducing the intensity ... // by just eating more fruits and vegetables. They ... antioxidants, are capable of accelerating and worsening an attack. ... to a diet low in antioxidants and their asthma ...
    ... of seagrass beds around the world has resulted ... and sediment stabilizers affecting the shallow-water ecosystems // ... resources and marine science, University of New Hampshire. ... deeply affected even the commercially valuable valuable shellfish ...
    ... have discovered how to measure the absorption of multi-walled ... nanotubes were discovered in 1991, and have a great ... storage in fuel cells. But despite their promise, a ... carbon nanotubes will impact the living environment. This discovery ...
    ... release on the 28th regarding a study on stethoscope accuracy ... that physicians with more experience // are better able to ... heart disease. The researchers felt that with a greater experience ... pathologic heart disorders., ,Publishing their findings in the March ...
    ... The New York State Department of Health has confirmed coliform ... by North Country Spring Water//, Ltd. For this reason ... recalling all of its bottled water products. Coliform bacteria ... presence of coliform bacteria in bottled water is a violation ...
    Cached Medicine News:Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 3Health News:Global Seagrass Decline Affects Shallow-water Ecosystems 2Health News:Global Seagrass Decline Affects Shallow-water Ecosystems 3Health News:Absorption Of Carbon Nanotube Measured In Worms Revolutionize Cancer Research 2Health News:Experienced Physicians Diagnose Heart Disease’s Earlie 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: